https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Background The Academic Research Consortium have identified a set of major and minor risk factors in order to standardize the definition of a High Bleeding Risk (ACR-HBR). Aims The aim of this study is to stratify the bleeding risk in patients included in the Cardio-Fribourg registry, according to the Academic Research Consortium for High Bleeding Risk (ACR-HBR) definition, and to report ischemic and hemorrhagic events at 2-year of clinical follow-up. Methods Between 2015 and 2017, consecutive patients undergoing percutaneous co
Like
Comment
Share
